Science and Research

T-high asthma phenotypes across life span

RATIONALE: In adults, personalised asthma treatment targets patients with T2-high and eosinophilic asthma phenotypes. It is unclear whether such classification is achievable in children. OBJECTIVES: To define T2-high asthma with easily accessible biomarkers and compare resulting phenotypes across all ages. METHODS: In the multicenter clinical ALL Age Asthma Cohort (ALLIANCE), 1125 participants (n=776 asthmatics, n=349 controls) were recruited and followed for 2 years (1 year in adults). Extensive clinical characterisation (questionnaires, blood differential count, allergy testing, lung function and sputum induction (in adults) was performed at baseline and follow-ups. Interleukin (IL)-4, IL-5 and IL-13 were measured after stimulation of whole blood with LPS or anti-CD3/CD28. MEASUREMENTS AND MAIN RESULTS: Based on blood eosinophil counts and allergen-specific serum IgE antibodies (sIgE), patients were categorised into four mutually exclusive phenotypes: "Atopy-only", "Eosinophils-only", "T2-high" (eosinophilia+atopy) and "T2-low" (neither eosinophilia nor atopy). The T2-high phenotype was found across all ages, even in very young children in whom it persisted to a large degree even after 2 years of follow-up. T2-high asthma in adults was associated with childhood onset suggesting early origins of this asthma phenotype. In both children and adults, the T2-high phenotype was characterised by excessive production of specific IgE to allergens (p<0.0001) and, from school age onwards, by increased production of IL-5 after anti-CD3/CD28 stimulation of whole blood. CONCLUSIONS: Using easily accessible biomarkers, patients with T2-high asthma can be identified across all ages delineating a distinct phenotype. These patients may benefit from therapy with biologicals even at younger age.

  • Maison, N.
  • Omony, J.
  • Illi, S.
  • Thiele, D.
  • Skevaki, C.
  • Dittrich, A. M.
  • Bahmer, T.
  • Rabe, K. F.
  • Weckmann, M.
  • Happle, C.
  • Schaub, B.
  • Meier, M.
  • Foth, S.
  • Rietschel, E.
  • Renz, H.
  • Hansen, G.
  • Kopp, M. V.
  • von Mutius, E.
  • Grychtol, R.
Publication details
DOI: 10.1183/13993003.02288-2021
Journal: Eur Respir J
Work Type: Original
Location: ARCN, BREATH, CPC-M
Disease Area: AA, PLB
Partner / Member: ALLIANCE, CAU, FZB, Ghd, HMGU, MHH, UKSH (Kiel), UKSH (Lübeck), UzL
Access-Number: 35210326

DZL Engagements

chevron-down